Call for Abstract

International Conference and Exhibition on Pharmaceutical Development and Technology, will be organized around the theme “Discover the Difference and Develop the Possibilities for Shaping Future”

PharmaTech 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in PharmaTech 2017

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

In the past Physical pharmacy is associated with the area of pharmacy that deals with the quantitative and theoretical principles of science as they applied to the practice of pharmacy .But now a days physical pharmacyattempted to integrate the factual knowledge of pharmacy through the development of Broet principles .Pharmacist should have the knowledge about the compatibility, Stability and biological reaction of drug. Physical pharmacy is a branch of pharmaceutics to change the drugs from one state to other state, changes the action by physically with the applications of the theories.

  • Track 1-1Pre-Formulation Studies
  • Track 1-2Rheology
  • Track 1-3Thermodynamics
  • Track 1-4Chemical Kinetics
  • Track 1-5Polymorphism
  • Track 1-6Micromeritics

Track 02: Biopharmaceutics and Pharmacokinetics

Bio pharmaceutics examines the interrelationship of the physical/chemical properties of the drug, the dosage form (drug product) in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption. The importance of the drug substance and the drug formulation on absorption, and in vivo distribution of the drug to the site of action, is described as a sequence of events that precede elicitation of a drug's therapeutic effect. Whereas Pharmacokinetics deals with the characteristic interactions of a drug and the body in terms of its absorption, distribution, metabolism, and excretion

First, the drug in its dosage form is taken by the patient either by an oral, intravenous, subcutaneous, transdermal, etc, route of administration. Next, the drug is released from the dosage form in a predictable and characterizable manner. Then, some fraction of the drug is absorbed from the site of administration into either the surrounding tissue, into the body (as with oral dosage forms), or both. Finally, the drug reaches the site of action. A pharmacologic response results when the drug concentration at the site of action reaches or exceeds the minimum effective concentration (MEC). The suggested dosing regimen, including starting dose, maintenance dose, dosage form, and dosing interval, is determined in clinical trials to provide the drug concentrations that are therapeutically effective in most patients. This sequence of events is profoundly affected—in fact, sometimes orchestrated—by the design of the dosage form and the physicochemical properties of the drug.

  • Track 2-1Drug Pharmacokinetics
  • Track 2-2Pharmacodynamic studies
  • Track 2-3Pharmaceutical Analysis
  • Track 2-4Clinical Applications of Pharmacokinetics
  • Track 2-5Bioavailability & Bioequivalence
  • Track 2-6Clinical data management

Pharmaceutical Formulation is the process in which different chemical substances i.e., active chemical substances will combined together to produce a medical compound i.e., medical drug. This process involves production of drug which characterized by two things: first it must be a stable product, second it must be acceptable to the patient who will use it. Besides that in case of synthesis of an oral medication (tablet or capsule) it will contain a variety of ingredients besides the drug itself so it is an obligate matter to be sure that all of these ingredients must be incorporate with each other. Therefore it is very important to do a lot of formulation studies in order to detect the point of incorporation. Besides that formulation studies must focus on other factors like particle size, polymorphism, pH and solubility, in order to check whether these factors will effect on bioavailability of the drug or not.

  • Track 3-1Solid Dosage Forms
  • Track 3-2Powder Dosage Forms
  • Track 3-3Liquid and Semi-Solid Dosage Forms
  • Track 3-4Parenteral Dosage Forms
  • Track 3-5Aerosols

Track 04:Optimization Techniques in Pharmaceutical Formulation and Processing

The term Optimize is defined as “to make perfect”. It is used in pharmacy relative to formulation and processing. It is involved in formulating drug products in various forms. It is the process of finding the best way of using the existing resources while taking in to the account of all the factors that influences decisions in any experiment. Final product not only meets the requirements from the bio-availability but also from the practical mass production criteria It helps the pharmaceutical scientist to understand theoretical formulation and the target processing parameters which ranges for each excipients &processing factors In development projects, one generally experiments by a series of logical steps, carefully controlling the variables & changing one at a time, until a satisfactory system is obtained. It is not a screening technique.

  • Track 4-1Concept of Optimization
  • Track 4-2Optimization Parameters
  • Track 4-3Classical Optimization
  • Track 4-4Statistical Design
  • Track 4-5Design of Experiment

The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all. On the other hand, the very slow progress in the efficacy of the treatment of severe diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. From this, new ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, biorecognition, and efficacy of drugs were generated. These new strategies, often called drug delivery systems (DDS), are based on interdisciplinary approaches that combine polymer science, pharmaceutics, bioconjugate chemistry, and molecular biology. For over 20 years, researchers have appreciated the potential benefits of nanotechnology in providing vast improvements in drug delivery and drug targeting. Improving delivery techniques that minimize toxicity and improve efficacy offers great potential benefits to patients, and opens up new markets for pharmaceutical and drug delivery companies. Other approaches to drug delivery are focused on crossing particular physical barriers, such as the blood brain barrier, in order to better target the drug and improve its effectiveness; or on finding alternative and acceptable routes for the delivery of protein drugs other than via the gastro-intestinal tract, where degradation can occur.

  • Track 5-1Controlled Drug Delivery Systems
  • Track 5-2Biochemical and Molecular Biology
  • Track 5-3Micro Particulate Drug Carriers
  • Track 5-4Monoclonal Antibodies
  • Track 5-5Drug Targeting
  • Track 5-6Drug Carrier Systems
  • Track 5-7Transdermal Drug Delivery Systems

The drug delivery technology landscape is rapidly evolving with new classes of pharmaceuticals and biologics fuelling this revolution. The last few decades have witnessed the emergence of several drug delivery technologies including hydrogels, liposomes, microparticles, nanoparticles, and polymers. The growth of drug delivery solutions is of increasing importance to pharmaceutical companies, and has resulted in significant changes in the drug delivery landscape. The future growth projections for these devices are increasing, causing a number of innovative drug delivery systems to be introduced each year. With significant paradigm shifts in drug discovery and development, the industry is also gearing up to adopt alternative drug delivery strategies in order to further facilitate drug development. Opportunities have significantly increased in the last few years. Pharmaceutical companies are collaborating with drug delivery firms to effectively target patient concerns. Newer methods, such as transdermal technologies, intelligent delivery systems capable of modulated delivery, nasal delivery and skin-based delivery technologies, have come up. And the change in the outlook of the drug delivery industry is further facilitating a better understanding of market dynamics, encouraging innovation for alternative technologies and giving rise to competition

  • Track 6-1Carbon Nano tubes
  • Track 6-2Hydro gels
  • Track 6-3Auto-Injectors
  • Track 6-4Stimuli-Responsive
  • Track 6-5Needle-Free Injectables
  • Track 6-6Nanotechnology
  • Track 6-7Colon delivery system
  • Track 6-8Pulsatile Drug Delivery System

Most of the new chemical entities coming out from High-throughput screening in drug discovery process are failing due to their poor solubility in the water. Poorly water-soluble drugs show many problems in formulating them in conventional dosage forms. One of the critical problems associated with poorly soluble drugs is too low bioavailability. The problem is even more complex for drugs belonging to BCS CLASS II category, as they are poorly soluble in both aqueous and organic media, and for those drugs having a log P value of 2. There are number of formulation approaches to resolve the problems of low solubility and low bioavailability. These techniques for solubility enhancement have some limitations and hence have limited utility in solubility enhancement. Nanotechnology can be used to resolve the problems associated with these conventional approaches for solubility and bioavailability enhancement. Nanotechnology is defined as the science and engineering carried out in the nanoscale that is 10-9 meters. The present article describes the details about nanosuspensions. Nanosuspensions consist of the pure poorly water-soluble drug without any matrix material suspended in dispersion. A nanosuspension not only solves the problems of poor solubility and bioavailability but also alters the pharmacokinetics of drug and thus improves drug safety and efficacy. The conventional dosage forms thus may result in over- or under-medication and poor patient compliance. These challenges can be overcome by applying novel drug delivery systems that offer benefits like reduction in dose frequency, lowering of dose size, site specific targeting, enhanced permeability, and improvement in oral bioavailability. Nanotechnology is a promising strategy in the development of drug delivery systems especially for those potent drugs whose clinical development failed due to their poor solubility, low permeability, inadequate bioavailability, and other poor biopharmaceutical properties. The most common nanotechnology based strategies used in development of delivery systems are nanoemulsions, dendrimers, micelles, liposomes, solid lipid nanoparticles, polymeric nanoparticles, carbon nanotubes, and so forth, which provide controlled, sustained, and targeted drug delivery. The nanotechnology based systems have extensively been investigated for improvement of the bioavailability of antihypertensive drugs

  • Track 7-1Nano crystals
  • Track 7-2Nanojet Technology
  • Track 7-3Solid Lipid Nanoparticles (SLNs)
  • Track 7-4Dendrimers
  • Track 7-5Self-Nanoemulsifying Drug Delivery System (SNEDDS)
  • Track 7-6Nanoparticles
  • Track 7-7Proliposomes

Identifying drug targets plays essential roles in designing new drugs and combating diseases. Unfortunately, our current knowledge about drug targets is far from comprehensive. Screening drug targets in the lab is an expensive and time-consuming procedure. In the past decade, the accumulation of various types of study of science related data makes it possible to develop computational approaches to predict drug targets. Non-communicable diseases such as cancer, atherosclerosis and diabetes are responsible for major social and health burden as millions of people are dying every year. Out of which, atherosclerosis is the leading cause of deaths worldwide. The lipid abnormality is one of the major modifiable risk factors for atherosclerosis. Both genetic and environmental components are associated with the development of atherosclerotic plaques. Immune and inflammatory mediators have a complex role in the initiation and progression of atherosclerosis. Understanding of all these processes will help to invent a range of new biomarkers and novel treatment modalities targeting various cellular events in acute and chronic inflammation that are accountable for atherosclerosis. Several biochemical pathways, receptors and enzymes are involved in the development of atherosclerosis that would be possible targets for improving strategies for disease diagnosis and management.

  • Track 8-1Novel Drug Target Approach for cancer
  • Track 8-2Novel Drug Target Approach for tuberculosis
  • Track 8-3Novel Drug Target Approach for atherosclerosis
  • Track 8-4Novel Drug Target Approach for dementia
  • Track 8-5Novel Drug Target Approach for diabetes
  • Track 8-6Novel Drug Target Approach for HIV

Track 09: Industrial Pharmacy

Industrial pharmacy is an area of the pharmaceutical field that specialized in creating drugs and medications. Industrial pharmacists use the latest methods, technologies and processes to develop new and groundbreaking medications. They are also responsible for determining if medications developed by pharmaceutical companies have both the right ingredients and the correct amount of these ingredients. It’s a field in which pharmacists can make a real difference in the lives of people who use medications to treat a variety of illnesses and conditions.

Responsibilities and Duties

Industrial pharmacists research drug compounds and develop new medications based on research. They test medications for efficiency and safety, oversee the production process to ensure medications are produced accurately, and they engage marketing and promoting new drugs to consumers, hospitals and doctors' offices. An industrial pharmacist may also be responsible for conducting clinical drug trials and evaluating the results of these trials to gauge a drug’s effectiveness and to determine potential risks or side effects. As part of a drug trial, industrial pharmacists collaborate with other pharmaceutical companies, local and federal governments, and a variety of health care professionals to ensure trials are conducted safety and within federal or state guidelines for drug testing.

  • Track 9-1Aseptic Processing Operation
  • Track 9-2Manufacture and quality assurance
  • Track 9-3Drug information
  • Track 9-4Patent applications and drug registration
  • Track 9-5Clinical trials and post-marketing surveillance
  • Track 9-6Sales and marketing

Aerosol means packaging of therapeutic active ingredients in a pressurized system. Aerosols are depends on the power of compressed or liquefied gas to expel the contents from container. There are many advantages with these aerosols like 1.A dose can be removed without contamination material 2. The medication can be delivered directly to the affected area in a desired form such as spray, steam, quick breaking foam or stable foam.3. Irritation produced by the application of topical medication is reduced or eliminated.4. Ease of convenience of application5. Application of medication in thin layer.

  • Track 10-1Properties of active ingredients
  • Track 10-2Types of systems in aerosols
  • Track 10-3Manufacturing of pharmaceutical aerosols
  • Track 10-4Quality control for pharmaceutical aerosols
  • Track 10-5Evaluation parameters for pharmaceutical aerosols
  • Track 10-6Applications of Aerosols

Pharmaceutical engineering is a branch of pharmaceutical science and technology that involves development and manufacturing of products, processes, and components in the pharmaceuticals industry (i.e. drugs & biologics). While developing pharmaceutical products involves many interrelated disciplines (e.g. medicinal chemists, analytical chemists, clinicians/pharmacologists, pharmacists, chemical engineers, biomedical engineers, etc.), the specific subfield of "pharmaceutical engineering" has only emerged recently as a distinct engineering discipline. This now brings the problem-solving principles and quantitative training of engineering to complement the other scientific fields already involved in drug development.

  • Track 11-1Bioreactors
  • Track 11-2Fluid Mechanics
  • Track 11-3Design of process equipment
  • Track 11-4Materials and Operations Management
  • Track 11-5Equipment Design and Process Optimization
  • Track 11-6Advanced Pharmaceutical Operations
  • Track 11-7Pharmaceutical Dosage Form Technology

The application of scientific knowledge or technology to pharmacy, pharmacology, and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures and in the treatment of patients.

  • Track 12-1Active Pharmaceutical Ingredient (API)
  • Track 12-2Technology Transfer
  • Track 12-3Advanced Bio-pharmaceutics and Pharmacokinetics
  • Track 12-4Bioinformatics and Computational Biology
  • Track 12-5Quality assurance and other regulatory issues
  • Track 12-6Pharmaceutical Technology Assessment

Drug manufacturing (Pharmaceutical Manufacturing)  is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations, such as milling, granulation, coating, tablet pressing, and others. The changing pharmaceutical landscape is a popular discussion point as of late. Armed with a fresh, non-blockbuster-reliant business model and treatment options that are expanding from small molecules to a range of new, more targeted therapies, the industry is at what PwC calls, “a critical juncture.”

Parenteral drug delivery is the second largest segment of this transformative pharmaceutical market  eclipsed only by the more mature oral solid dosage forms  accounting for nearly 30 percent of total pharma market share. According to Survey, the market for parenteral drug delivery products is projected to rise over 10 percent annually to $86.5 billion in 2019.

  • Track 13-1Formulation and Pre-Formulation development
  • Track 13-2Pharmaceutical Manufacturing technology
  • Track 13-3Treatment Technologies
  • Track 13-4Discovery and Synthesis of Pharmaceuticals
  • Track 13-5Current challenges in Pharmaceutical marketing
  • Track 13-6Pharmaceutical Supply Chain Management

As developers and manufacturers of life-saving products, the world’s leading pharmaceutical companies play an important role in improving access to medicine for the world’s poor. Through their own initiatives and in collaboration with other relevant stakeholders such as multi-lateral organizations, governments and the global health community, these companies are increasingly helping to address the access to medicine challenge. In order to suitably capture the industry’s progress in line with society’s evolving expectations, the Access to Medicine Index methodology is systematically reviewed every two years. While maintaining as much consistency as possible for the purpose of trend analysis, the methodology is adjusted where needed. 

  • Track 14-1Modern Analytical Methodology
  • Track 14-2Technological Innovations
  • Track 14-3Microencapsulation
  • Track 14-4Synthesis of heterocyclic compounds
  • Track 14-5Chiral Separations
  • Track 14-6HPLC technology

The regulatory requirements of various countries of the world vary from each other. Therefore, it is challenging for the companies to develop a single drug which can be simultaneously submitted in all the countries for approval. The regulatory strategy for product development is essentially to be established before commencement of developmental work in order to avoid major surprises after submission of the application. The role of the regulatory authorities is to ensure the quality, safety, and efficacy of all medicines in circulation in their country. It not only includes the process of regulating and monitoring the drugs but also the process of manufacturing, distribution, and promotion of it. One of the primary challenges for regulatory authority is to ensure that the pharmaceutical products are developed as per the regulatory requirement of that country. This process involves the assessment of critical parameters during product development.

  • Track 15-1Pharmaceutical Legislations and Regulations
  • Track 15-2Pharmaceutical Laws, Regulations and Guidelines
  • Track 15-3Globalization and Harmonization
  • Track 15-4Intellectual property
  • Track 15-5TRIPS Agreement
  • Track 15-6Drug Regulatory Affairs

The role of medical devices in health care is essential. A medical device is an instrument, apparatus, implant, in vitro reagent, or similar that is used to diagnose, prevent, or treat disease or other conditions. This category includes news on product recalls, product safety, implants and prosthetics, new technological developments, robotic surgery, medical devices for use by medical professionals or patients. Medical devices and medical electronics are areas that had little to offer 100 years ago. However, there were three important existing technologies that led to many further developments over the following 100 years. These are the stethoscope, electrocardiography, and X-ray medical imaging. Although these technologies had been described and were available to some extent when the Proceedings  of the IEEE pages first appeared, they had yet to achieve the widespread use that they have today.

  • Track 16-1Modern Surgical Techniques
  • Track 16-2Biomedical Sensors
  • Track 16-3Nuclear Medicine Imaging
  • Track 16-4Therapies Based on Bioelectricity
  • Track 16-5Needle-Free Diabetes Care
  • Track 16-6Electronic Aspirin
  • Track 16-7MelaFind optical scanner
  • Track 16-8A Valve Job with Heart